Posology: A single 0.5 mL dose of Boostagen is recommended. Boostagen should be given in accordance with WHO and national recommendations or medical practices for booster vaccination and for maternal immunization in the second or third trimester preferably at least 15 days before the end of pregnancy, for protection of infants against pertussis. Boostagen can be used for tetanus prophylaxis in wound management. Tetanus immunoglobulin should be administered in accordance with existing recommendations.
Administration: Boostagen should be administered by deep intramuscular injection, preferably in the deltoid region. The skin over the site of injection should be cleaned before injection. Shake well before use. Do not use if resuspension does not occur after vigorous shaking. Open the needle cap of the pre-filled syringe, administer the total volume of 0.5 mL intramuscularly (IM).